Maximus, Inc. (MMS) Q2 2012 Earnings Report, Transcript and Summary

Greetings and welcome to the MAXIMUS Fiscal 2012 Second Quarter Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host Lisa Miles, Vice President of Investor Relations from MAXIMUS. Thank you Ms. Miles, you may begin.

Good morning. Thank you for joining us on today’s conference call. I would like to point out that we posted a presentation to our website under the Investor Relations page to assist you in following along with today’s call. With me today is Rich Montoni, Chief Executive Officer; and David Walker, Chief Financial Officer. Following Rich’s prepared comments we will open the call up for Q&A. Before we begin, I’d like to remind everyone that a number of statements being made today will be forward-looking in nature. Please remember that such statements are only predictions and actual events or results may differ materially as a result of risks we face including those discussed in Exhibit 99.1 of our SEC filings. We encourage you to review the summary of these risks in our most recent 10-K filed with the SEC. The company does not assume any obligation to revise or update these forward-looking statements to reflect subsequent events or circumstances. And with that, I’ll turn the call over to Dave.

Thanks, Lisa. Good morning everyone. Once again MAXIMUS reported another solid quarter of financial results with revenue increasing 7% to $243.5 million compared to last year. Growth in the quarter was driven by the Health Services segment. This was offset by the anticipated lower revenue in the Human Services segment that resulted from the revenue ramp-up on the Work Programme in the U.K. Operating income, excluding net legal recoveries, totaled $26.8 million in the second fiscal quarter with associated operating margins of 11%. As noted in this morning’s press release, we are revising our tax rates upward to account for a greater mix of business and higher tax rate jurisdictions. As part of this adjustment, second quarter results included discrete tax charge of $3 million or $0.09 per diluted share related to higher state taxes incurred in prior periods. In addition to this tax true up, we increased our tax rate for the year to 38%. As a result, second quarter GAAP income from continuing operations, net of taxes, totaled $14.2 million or $0.41 per diluted share. The $0.41 of earnings also includes a $0.01 benefit related to a legal insurance recovery. Excluding this $0.01 benefit and the $0.09 tax charge in the quarter, adjusted diluted earnings per share from continuing operations were $0.49. And as always, we’ve included a supplemental table in the PowerPoint Presentation to help investors understand the quarter’s highlights. The same table can also be found on the last page of this morning’s press release. Subsequent to quarter close, we completed the acquisition of PSI, an all-cash transaction, which Rich will cover in his prepared remarks. Let’s turn our attention to results by segment. The Health Services segment delivered another good quarter with revenue growing 17% to $161.2 million compared to the same period last year driven by the managed care expansion in Texas. The segment also benefited from organic growth from new work and strong volumes in existing programs. During the quarter, we completed contractually planned activities for the managed care rollout in Texas, which bolstered revenue in the first half of the year. We’ve since ramped down the managed care expansion activities and expect that contributions from this contract will return to more normalized levels beginning in the third quarter. For the second quarter of fiscal 2012, operating income for the Health Services segment was $18.2 million with an operating margin of 11.3%. We continue to experience favorable volumes in a couple of contracts, most notably in our federal Medicare appeals business with increased volumes generated by the Recovery Audit Contractors or RACs as they are more commonly known. Operating margin was lower compared to the same period last year principally due to normal contract lifecycle. This would include new programs that are in the first year of the business cycle as well as some recently re-bid contracts. During the quarter, we also had an increased amount of bidding proposal activities included in SG&A. And as we noted in the first fiscal quarter, the revenue expansion from the lower margin Texas contract dampened the operating margin in the quarter. Turning to Human Services, the segment performed in line with our expectations. Second quarter revenue for the Human Services segment totaled $82.3 million and was lower compared to last year as we transitioned to the United Kingdom Work Programme contract. Similarly, the U.K. contract lowered operating income in the quarter, which totaled $8.6 million with a margin of 10.5%. Despite the losses on the U.K. Work Programme in the current quarter, results were only slightly down compared to the same quarter last year. This is because last year’s results included a loss of $4.2 million on a fixed-price contract that has since been successfully resolved. Consistent with our prior guidance, the losses in the U.K. peaked in the second fiscal quarter and we still remain on track for the contract to break even in the fourth quarter. As a reminder, the nature of the program ties vendors to longer term outcome-based payments. As we’ve gained experience on the program, we started to achieve confirming data points that provide us with better trend data, improve our overall visibility and allow us to update our financial model. Based on this data, we expect that revenues will be lower than our previous forecast but the bottom line is still tracking in line with our original expectations. We now expect fiscal year ‘12 revenue from this contract to come in between $22 million and $24 million versus our prior estimate of $30 million. We are tweaking our fiscal year ‘13 and fiscal year ‘14 revenue down by only $5 million and now expect revenue of $70 million and $90 million, respectively. Our operating margin assumptions remain unchanged at 15% for these out years. The top line refinement is driven by a number of factors. So let me walk you through exactly what we’re seeing. First, as we mentioned last quarter, overall volumes are coming in higher than our original expectations. In addition, we’re starting to see the caseload mix self correct with volumes from the harder-to-serve cases picking up in the last 2 months and returning to levels that we anticipated in our original plan. The number of placements we’re achieving with the number of people we actually find a job for, are tracking as planned. The achievement of outcomes for those people that remain in the job for a specified period of time, typically 26 weeks or 13 weeks, are tracking a little softer than expected. Part of this softness is related to the outcome verification process, which the Department of Work and Pensions modified at the end of March. This modification should help our outcome achievement rates going forward. So when you add it all up, these factors create a short-term impact on revenue in fiscal ‘12 because of how revenue ramps over time. We have also closely managed costs so we are now expecting a loss in the range of $8 million to $9 million and remain on track to break even in the fourth quarter. But most importantly, we still believe that we’re fundamentally on target for fiscal year ‘13 and beyond and we remain optimistic on the longer-term outlook of the program. We firmly believe that the economics remain sound and we still expect the program to be a solid contributor to profitability over the life of the contract. Moving on to cash flow and balance sheet items. Net income in the quarter contributed to another quarter of strong cash flows. Cash flow in the fiscal second quarter was exceptionally strong driven most notably by solid receivable collections and favorable DSOs of 55 days. Cash provided by operating activities from continuing operations totaled $41.5 million for the second quarter with free cash flow of $36.4 million. Our balance sheet remained sound. And at March 31, we had $229.5 million in cash and cash equivalents of which approximately 51% was held overseas. During the quarter, we did not repurchase any shares in anticipation of the PSI acquisition. We purchased PSI with $67 million in cash and we also expect non-recurring merger related expenses of approximately $4 million. Before I hand the call over to Rich, I’ll wrap up with guidance. For fiscal 2012, we are updating our guidance to include the acquisition of PSI for the 5 months from May 1 through September 30. For fiscal 2012, we expect PSI to generate revenue in the range of $55 million to $60 million, of which approximately 40% will be attributable to the Health segment and the remaining 60% will be attributable to the Human Services segment. As a result, we now expect total company revenue to range between $1.03 billion and $1.06 billion, up from our prior estimate of $980 million to $1.015 billion. We are maintaining our earnings estimates for fiscal 2012 and still expect adjusted diluted earnings per share from continuing operations to range between $2.20 and $2.30, which excludes non-recurring acquisition related charges, legal recovery benefits and the discrete tax charge taken in the second quarter. We expect that the acquisition of PSI would provide up to $0.05 of accretion, which is offset by the increase in our full year tax rates to 38%. We also wanted to update you in the status of the change order that we discussed on our last earnings call. We are making significant progress as we continue to work collaboratively with the client on the overall scope of the modification. We still expect the modification to be approximately $0.08 per share and to be completed in the back half of the year and more specifically in the fourth quarter. Furthermore, we still expect to achieve our guidance range with or without the change order, but depending on the nature, extent and amount of the range order, it could provide some upside to the top of our forecasted range. We are also updating our cash flow guidance. We now expect cash provided by operating activities derived from continuing operations to be in the range of $100 million to $120 million. And we expect free cash flow from continuing operations to be in the range of $75 million to $95 million. And with that, I’ll turn the call over to Rich.

Thanks, David, and good morning everyone. We’re pleased to report another solid quarter, which keeps us on track to achieve our full year guidance. On Tuesday, MAXIMUS completed the purchase of PSI, so I’d like to begin with the specifics surrounding the acquisition. One of the ways that MAXIMUS drives long-term shareholder value is to use our excess cash in a variety of ways, including strategic acquisitions. At the end of last fiscal year, we stated that one of our short-term goals was to make qualified acquisitions. We’ve been deliberately selective with our acquisition activity, seeking opportunities that complement and fit well within our current business portfolio. We are seeking close-fitting companies that we understand well and that we view as low risk with attractive upside. The completion of the PSI acquisition on April 30 fits this model perfectly and is an important step towards achieving our short-term goals. Like MAXIMUS, PSI has a core focus on the administration of government health and human services programs. The PSI portfolio includes Medicaid and CHIP administration, child support enforcement and welfare-to-work contracts as well as specialized consulting services. Many of these contracts allow us to grow our market share and cultivate new client relationships. As we blend the PSI contracts into our business, it’s important to note that these contracts currently run below our 10% to 15% operating margin range. This is due in part to several key projects that are in start up phase. Our long-term goal is to institute many of the same business optimization strategies that we put into place 6 years ago at MAXIMUS. We are confident that we can bring these margins up to at least 10% over the next several years. A full integration effort is underway and our goal is to achieve a swift but thoughtful combination of our businesses. We expect a smooth and seamless integration. And a MAXIMUS PSI team is already implementing a detailed integration plan covering all business areas. Throughout the transition period, we are maintaining a laser-sharp focus on the service delivery for our clients. This remains our #1 priority. The strategy behind the acquisition centers on the services we provide to our government clients. The addition of PSI improves our ability to help our clients meet their challenges of running efficient and effective public programs. The combined organization yields a great number of benefits to the clients, both firms. These benefits include; increased operational resources, efficient shared services, enhanced subject-matter expertise, innovative BPO and technology and financial stability. A high degree of overlap exists between the operations of MAXIMUS and PSI making this acquisition a natural fit. We are excited to blend the PSI contracts into our domestic Health and Human Services portfolio. And I’d like to take a moment to walk you through the benefits of the acquisition by segment. We’ve included several slides in today’s presentation that give you a high-level overview of the enhanced portfolio and the market-share landscape. Starting with Health Services, PSI brings 7 Medicaid and CHIP contracts, including those with marquee CHIP clients, such as Georgia and Florida. With the addition of PSI’s health portfolio, MAXIMUS serves an additional 2 million CHIP and Medicaid beneficiaries. MAXIMUS has a long-term history of effectively serving many states, in particular, larger Tier 1 states with complex programs and diverse beneficiary populations. With the addition of PSI, we gain several additional Tier 1 clients including Georgia and Florida. In addition to longstanding and excellent client relationships, PSI has developed innovative approaches to meeting the unique policy and program requirements in the states they serve. The combination of MAXIMUS and PSI offers a broad range of capabilities both technical and operational, and additional economies of scale to meet the diverse needs of our clients better. As health reform continues to develop and states plan their rollout of their health insurance exchanges, MAXIMUS and PSI together offer additional options and long-term stability for existing clients while bringing together 2 highly experienced and innovative firms to address the needs of state clients and the federal government. On the Human Services side, the acquisition adds new welfare-to-work and consulting contracts and meaningfully grows our market share in child support. PSI provides additional qualifications that now open up entirely new adjacent child support markets where MAXIMUS has historically not been a meaningful player. PSI brings a long history of success in the child support market with extensive experience and industry-leading best practices. PSI also offers more operational resources to tackle the increasing demand and fill the gaps where we may have been resource-constrained in the past. And as market demand for our services continues to increase, the acquisition brings more resources to bear as we grow the business and capitalize on new Health and Human Services opportunities, both here in the U.S. and abroad. We’re really excited about the breadth and depth of experience and innovation that PSI employees bring to MAXIMUS. We share a common commitment of serving our government partners, and ultimately improving the lives of citizens around the world. So we’re pleased to wrap up the acquisition and welcome the PSI employees to the MAXIMUS team. Now turning to Health Care Reform in the U.S. The implementation of ACA continues to be a pressing concern for states of all sizes and in different phases of reform. We recognize that some states are waiting to see if the Supreme Court decision impacts the Health Care Reform Law and while we can’t speculate on this decision, we’ve completed a thorough analysis of our strategy under the various potential outcomes. As we mentioned before, one of the variations of health reform is a gradual ramp up on the establishment of exchanges on a state-by-state basis. An April 17 Reuters piece noted that some states are moving ahead with reform regardless of whether the Supreme Court overturns pieces of ACA or the entire law. To date, 16 states and the District of Columbia have legislation or executive orders directing the implementation of ACA. These states, along with other states that have the political support for the law’s goals, will continue pursuing some level of reform and many are looking at the viability and sustainability of different models in the event ACA is overturned. Regardless of the direction or speed of reform, the underlying fundamental social challenges won’t go away just because the law is changed or modified. Individuals who aren’t eligible for public programs or don’t have access to employee response of coverage are simply more likely to turn to emergency rooms as their primary source of medical treatment. Underserved and uninsured populations still must be connected to coverage that best meets their individual needs. To accomplish this goal, states will need to retain cost-effective solutions from partners who are independent and free from any conflict of interest. In the meantime, the health insurance exchange procurement marketplace is rolling out just as we anticipated with the initial focus on technology bids designed for system integrators. While MAXIMUS is not a system integrator, we are selectively participating in these initial bids and that’s in a subcontractor role. For us, these initial bids are more of a “toe in the water” opportunity. We view them as tactical presence to maintain an awareness as the HIX market continues to progress. Once the technology is built out, the operational focus will shift to the BPO and healthcare consumer engagement and service. These administrative functions are right in the sweet spot for MAXIMUS and we look forward to applying our experience, independence and best practices from Medicaid and CHIP to health insurance exchanges. Moving onto an update on our international activities. In the U.K., our Work Programme operations are up and running and that’s at full speed and they remain fundamentally on track. As David noted, we still expect to break even in the fourth quarter of fiscal ‘12. The lower revenue forecast for the year is balanced by the recent process modifications implemented by the Department of Work and Pensions. These modifications are expected to improve the outcome verification process going forward. As we’ve talked about historically, we run these programs with a large portion of variable cost, which allows us to efficiently and effectively manage resources to achieve our bottom line results. Much like under the previous Flexible New Deal program, the U.K. government plans to publish performance outcomes for work program vendors. These results are expected in the fall, but the U.K. employment minister has stated he anticipates the results could lead to a shakeout in the supply chain of vendors. We believe our performance has been strong relative to the pack and we believe we are well on our way to making this a successful project. We also have great news to share from Australia today. We recently signed a 3-year $450 million extension to our Job Services Australia contract. As a result of our exceptional performance as publicized in the star rating, we picked up some additional work in Ipswich, South Brisbane and Western Downs through the reallocation process. This new work increases our national caseload by approximately 3%. Moving onto new awards and the sales pipeline. As a reminder, fiscal ‘12 continues to be fairly a lot of rebids compared to fiscal ‘11, which had several large rebid awards. At April 25, our fiscal year-to-date signed contract wins totaled $812 million, which includes the Australia contract extension. New contracts pending, or those that are awarded but unsigned, totaled $284 million. Our pipeline of sales opportunities at April 25 remains strong at $1.7 billion. And as a reminder, investors should expect routine fluctuations between the pipeline and the new sales categories. These ships are driven by the different stages in the procurement process as well as the timing of when contracts are awarded and ultimately signed. In summary, we continue to make solid progress on our short-term goals. We are successfully ramping up operations in the U.K. and remain on track to achieve breakeven status in the fourth quarter. We continue to move forward with our business development plans by winning our fair share of Health Care Reform contracts. And we have completed the strategic acquisition of PSI, a growth platform that will help us drive long-term value for our shareholders. We do the acquisition as a prudent use of cash as we drive growth in our core markets. Moving forward, we intend to employ the same fundamental principles of cash deployment, which include investing in business development and growth prospects across all our markets, including organic and through acquisition, continuing our quarterly cash dividend strategy, and finally, executing on our share buybacks in an opportunistic fashion. But most importantly, the team remains committed to growing the business and delivering long-term shareholder value. And with that, let’s open it up for questions. Operator?

[Operator Instructions] Our first question comes from Charlie Strauzer of CJS Securities.

Rich, if you could give us a little bit more color on the PSI acquisition and how you expect the year to kind of unfold with the addition of that from a revenue and earnings perspective?

I’d be pleased to do that. Let me take it this way. We put some data out there as it relates to PSI. We expect that this year it’s going to contribute I think the midpoint is $57 million in revenue. And keep in mind that’s for 5 months. The acquisition was completed on May 1. So when we take PSI and consider the fact that it has lower margins, it’s about 60% into our Human Services segment, 40% into our Health segment, the way we see the rest of the year unfolding is as follows: On a consolidated basis from a top line perspective, we expect that our Health Services segment, we expect the full year revenue growth will be driven principally in the entire corporation by Health Services plus PSI. And as we discussed I think last quarter, the Health Services, its organic revenue is expected to be stronger in the first half of the year and this is due to a spike that we’re getting from the expansion in Texas. Organically for Health Services segment, we expect that’s going to come down in the back half of the year. But when you put PSI into the mix that will bolster Q4 by an anticipated $8 million, so we see overall, with PSI, the Health segment being relatively consistent in Q3 with a bolster in Q4. That Q4 relates to the change order we anticipate to receive. That’s order of magnitude of $8 million. So that’s the story with the Health Service segment with PSI. As it relates to the Human Services side, organically excluding PSI, that segment’s revenue for fiscal ‘12 is expected to be relatively flat compared to ‘11 with quarterly revenue lower in the first half of the year and that’s really a result of the startup in the U.K. and we expect that, that’s going to ramp back up in the second half of the year. When we put PSI into the mix of the Human Services side, we see a significant increase in Q3 and Q4 for its revenue. And again to emphasize, that change order we expect in the fourth quarter, when we add that all together, we end up with our guidance range to be $2.20 to $2.30, which is the same as the prior EPS adjusted earnings per share.

Excellent. And just one quick follow-up, Richard, because when you talk about ACA, and the Supreme Court is obviously reviewing that, remind us again let’s say ACA is repealed or done away with and has to kind of go back to the drawing board. I know there is a lot of states are saying that the health exchanges are still going to move forward. What is the states’ kind of thinking there that – why would they move forward with those if the market is not in place, just remind us again there?

Charlie, that’s a great question. And as you can imagine, we are day in and day out very, very much involved in the details at the state level as it relates to it. I’m going to make a fundamental commentary and then I’m going to ask Bruce Caswell who is in charge of this line of business for us and is very much involved in it. But fundamentally, what I think is going on is the Supreme Court, they will go through their deliberations from a legal perspective but it’s very important to remind ourselves that what we’re trying to deal with here is a very, very large social challenge. There are millions of people out there who otherwise don’t have health care, need health care. And there is another interesting trend that’s very much playing into it and that’s the number of employers who -- the decreasing number of employers who are offer -- not offering -- I’m sorry a decreasing number of employers offering health care to their employees. So there are more individuals, even employed individuals who are not receiving health care from their employer. That adds an additional pressure to these government health plans. So we got a very large social problem, the states have to tackle it regardless of the Supreme Court deliberations. And Bruce, why don’t you talk a little bit about what you’re seeing at the state level on the marketplace here.

Sure Rich. As Rich mentioned, the dynamics have been in place for some time and really in a sense have not changed the underlying social drivers. And many states, as you’re well aware, had started to address this issue even prior to the creation of the act and if I’m looking at their insurance markets, addressing potential reforms and looking at ways to increase and broaden coverage for their populations. It’s important to note that there are a total of 24 states that have either signed legislation, have a work around in place through executive order or similar or have a live bill for exchanges. So that really is nearly 50% of the country where there is broad, I call, legislative support in order to enact these types of reforms around an exchange concept and the fundamental principle of a more transparent market and efficient market and consumer choice-driven market is sustained. That’s bolstered by the availability of several money that is flowing into these states that they don’t need to give back through the establishment grant process. So there’s an infrastructure being built and there is some political will and legislative progress that I think is sustainable going forward.

Our next question comes from Constantine Davides of JMP Securities

I guess first just on the U.K., can you talk a little bit more about what the process modifications are there in terms of the outcomes verification? Why is this sort of a depressing effect on revenue, but yet you call out that it’s going to be a positive driver of outcomes going forward?

We’d be pleased to answer your question. And as we get into the U.K. discussion, I think it’s important to understand the basis for the revision. And I’ll get to your detailed question in a moment, Constantine, but what’s happening here is, for this relatively new program, every quarter we have more experience, we become more confident in our model. We refine the model based on real experience to date, real data. I am pleased to say that the front-end drivers are proving out, actually a bit more favorable. We talk about them being volumes more favorable, the mix shift I think last time we talked we were seeing a mixed shift towards the easier population to serve. That seems to be righting itself and coming back to what we had initially expected. Placements are on track. It’s the outcomes that have been a bit softer and in part that has been a function of the verification process. And as we go through this, in order to be entitled to an outcome payment, we have to verify that we in fact place that individual, and that individual reached the outcome payment point, which depending upon the type of individual might be 13 weeks or 26 weeks. The process that the government has had in place basically hung up some of these individuals in the verification process and it’s a meaningful number. And the government has since remedied that situation to facilitate clearing the backlog in the short term and then remedying the process on a go-forward basis. In particular, the prior model had called for a government verification of the ongoing employment achieving the employment hurdle. They’ve modified that to allow -- and previously they also required us to verify with the employee, now they’re allowing us to verify with the employer, which as you can imagine is easier to do than contacting the employee in some cases.

Okay, that’s helpful. And maybe just piggybacking on the U.K., the DWP posted some award on the health assessment side and wondering if, I don’t want to jump the gun here, but wondering if you can talk a little bit about the opportunity there because it looks like you guys picked up a few lots.

Which specific -- this is Bruce Caswell. Which specific awards are you referencing?

The health and disability framework.

Indeed. And again, like the Work Programme, this was just a framework award. So this gives you the ability to then compete for the specific regions in which you’ve earned that privilege. So we’re excited about that having passed through that qualification process and we’re evaluating that opportunity and the potential to partner in that area going forward. So it’s an important first step and I think it’s a good validation of the capabilities of the firm in that adjacent market.

But to be clear, it’s a framework award as opposed to a specific award or contract award. So there’s really no revenue associated with it at this point in time.

Got it. And then lastly, just one for Dave, on the tax issue, can you just tell us when that came to your attention and should we be modeling, I guess should we be modeling 38% as kind of the 3Q, 4Q tax rate?

Yes a good question. It just relates to state taxes and we recently, this quarter, completed our corporate tax return. So a normal part of the process is to review the prior year estimates related to taxes. So the largest portion of this $0.09 relates to fiscal ‘11 and it’s a true up that’s done when the tax return gets completed, which again happened this quarter. We treat it as a discrete charge and to accountants that means we’re booking it so it doesn’t confuse what is a normalized provision. So the normalized provision, which shows the higher impact for fiscal ‘12 of the state rate is 38%. So the full year actually retroactive and going forward is 38% and this $0.09 is a one-time charge, which kind of takes the difference in the expenses this quarter. And if you kind of look to your remodeling out past fiscal ‘12, it’s important to point out that the U.K., which had a loss this year, and has a lower tax rate, actually hurts us because you have a loss, so you get less tax benefit. So if you were thinking about beyond ‘12, 37% is a more appropriate rate.

And Constantine to answer your question, I think Dave may have answered it, but this came to our attention this quarter.

Our next question comes from Brian Kinstlinger of Sidoti & Company

The first question I had and I joined late so sorry if you mentioned it, but just heard the answer how the outcomes, basically some of them may have been missed because of verification. Are you able to recoup that once they realize and you are able to give them verification of when the payments were due?

Brian, indeed we are. We have a number that are in the queue subject to verification. Realistically, I think a good percentage of them will be deemed to be verified and naturally we would get the benefit of that.

And then on the discussion on the U.K. shakeout of vendors, how do you -- in light of how the original competition went based on pricing, how do you think that the DWP weighs price versus market share going forward?

Well that’s a great question. I think it’s a question that many governments will be facing in the future, how they balance the right point on curve in terms of the benefits and costs and I think many are going to find that the benefit to the government is not maximized when they choose the lowest price. They will receive fewer placements. They will receive service that will not be as efficient or that will not be as effective as the government would like. So I think clearly, I would expect that the U.K. government is taking a hard look at that and perhaps they will adjust their weightings as we go forward.

If I can ask one more question. The -- seeing how the outcome-based contract has been working out and in light of the pipeline of several countries looking at changing their welfare-to-work program that you discussed in the past, are you prepared to take on more outcomes-based pricing right now? Is that how you think the market is going to go forward on new contracts?

I think it’s going to be a blend. We will entertain on a -- an opportunity-by-opportunity basis new work. I expect there’ll be some that will -- we will feel comfortable moving forward. I expect there’ll be some where we will not move forward. So we’ll be selective. It’s -- if we think it’s an opportunity that we feel comfortable, we can deliver the results based upon the terms and conditions, we would move forward. But it’s not a categorical yes to all opportunities. It would have to depend upon the facts and circumstances.

Our next question comes from Frank Sparacino of First Analysis

I just want to be clear on the U.K., the revision for 2012. I mean I understand the comments made around the outcome as being temporary. So there obviously had to be something from a permanent standpoint that forced the reduction, it’s just not clear to me what that exactly is.

Frank, let me try to talk about this. Again when we first estimated the revenue and cost and operating income, this program was yet to be launched. And as it launches, we go through and collect actual data and when you study this program, you’re going to find that the drivers to revenue and to ultimate operating income are the volumes that we receive, the mix of the cases that we receive, the percentage of those cases that we actually place, the percentage of those placements that actually get to the initial outcome payment. It’s either 13 weeks or 26 weeks. And then the percentage of those individuals, once they’re placed in a job what percentage remain in that job by week for up to a number of months. So the formula is fairly complex. It’s based upon a number of interrelated variables. So every month as we’ve progressed and we learn actual experience, we’ve changed the model accordingly. So the primary answer is that we simply received direct data to modify the model. And as a result, when we study those individual variables, we have favorable variances on the volume side, on the mix side, on the placement side. It’s the outcomes that we’ve modified or we’ve taken down our assumption as it relates to what percentage of those individuals will actually hit the outcome phase. So it’s a minor tweak. What that does, Frank, it actually just takes some revenue and pushes it to the right and it brings revenue a little bit down in each of the periods that we’ve been forecasting.

Okay. And then just a follow-up. Obviously there was quite a bit of news in the first quarter as it relates to the Work Programme and I’m curious if there is -- if you’ve seen any impact or a flaw in terms of closer scrutiny of the program or any potential hurdles or roadblocks as a result of that?

Yes I think that there has been a fair amount of press in the United Kingdom and there’s been one firm in particular that’s received an awful lot of negative attention. I do think categorically that programs like this will always be under the watch eye. Government programs do get an incredible amount of scrutiny, in part because we’re spending public funds and also in part because oftentimes it’s in the intersection of political differences. So it’s history that these programs do get a lot of attention. And as a result, it’s very important for anybody operating in this space to pay attention to their billing integrity, to put forth really best efforts, best practices in terms of the integrity of the bills that are submitted to the government. And whenever a firm slips up and it’s inevitable there will be isolated instances so it’s a matter of having good solid billing integrity program, which MAXIMUS does. But those that don’t are subject to criticism and it’s important to the industry as a whole that it’s isolated and it doesn’t become an industry problem. At that point, it could jeopardize an entire program. But I don’t think we’re there. I think in this particular case, the department is very comfortable with the performance of certain vendors including MAXIMUS and I think the department as well as MAXIMUS remains very, very much committed to the success of the program. It’s really intended to address head on a very important social issue and fiscal issue that they’re trying to deal with.

[Operator Instructions] Our next question is a follow-up from Constantine Davides.

One quick one on PSI, you called out $4 million of, I guess, integration expenses. Is that contemplated in the $2.20 to $2.30 EPS guidance or is it excluded and I guess is that a 3Q event or is it spread evenly across the next couple of quarters?

It’s excluded and it’ll largely be in Q3, a little bit coming into Q4.

[Operator Instructions] Our next question is another follow-up from Brian Kinstlinger of Sidoti & Company.

Just one question. In the first half of the year, we’ve seen the shift in -- towards managed care with Texas help pull [ph] your earnings and revenue. I’m curious, is there any particular state right now out there that is about to go through a similar process that will help drive incremental revenue and earnings to that? Maybe not to that degree, given the state of them but are going through something that’s going to temporarily spike your earnings?

Bruce Caswell, would you respond to that please?

Happy to. Yes we continue to see this trend in the marketplace, as we’ve indicated that we expect to continue really through 2013. The states are moving populations that historically you might not have considered eligible for managed care into these programs. Without mentioning any specific states, there are activities really across the country, including some states where MAXIMUS is not a current provider that are seeking to ship populations, for example from primary care case management models into full capitated risk based managed-care models. So we see it as creating strong market opportunity, not just within our current client base but beyond.

Our next question is another follow-up from Frank Sparacino.

Just wanted to follow up on the Australia rebid. I’m curious, as it relates to pricing on that contract relative to what you experienced the prior time around. And then also just from a competitive standpoint, what the process was like.

Very, very pleased to answer that question because it’s a very significant highlight to not only the quarter but to the year. This is our largest contract I believe. And this one, Frank, the Australian government is very interesting in terms of how they go to market here and it speaks to the earlier question about governments’ bidding price and whether or not we would move forward. This particular government I think has a great model. They don’t bid price. They simply say to the vendors, this is the price that we will pay, they have determined what’s the optimal price for them to maximize their situation. So you don’t bid price, you’ve got qualifications and they hold your feet to the fire in terms of getting the results done. This particular case was not a rebid, they basically went and extended the contract of current providers who were performing at a 3-star or a better rating. They have a 4-star rating, I’m sorry a 5-star rating process that rates the performance of the individual vendors. So, they just automatically extended those who are 3 stars or better, which is even better than a rebid situation. Next question.

It appears you have no further questions at this time. This concludes today’s teleconference. You may now disconnect your lines at this time. And thank you for your participation.

Thank you.